Caseware UK (AP4) 2024.0.164 2024.0.164 2024-08-312024-08-312falsefalse2023-09-01No description of principal activity2trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09889322 2023-09-01 2024-08-31 09889322 2022-09-01 2023-08-31 09889322 2024-08-31 09889322 2023-08-31 09889322 c:Director1 2023-09-01 2024-08-31 09889322 c:Director2 2023-09-01 2024-08-31 09889322 d:PlantMachinery 2023-09-01 2024-08-31 09889322 d:PlantMachinery 2024-08-31 09889322 d:PlantMachinery 2023-08-31 09889322 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 09889322 d:OfficeEquipment 2023-09-01 2024-08-31 09889322 d:OfficeEquipment 2024-08-31 09889322 d:OfficeEquipment 2023-08-31 09889322 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 09889322 d:OwnedOrFreeholdAssets 2023-09-01 2024-08-31 09889322 d:CurrentFinancialInstruments 2024-08-31 09889322 d:CurrentFinancialInstruments 2023-08-31 09889322 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 09889322 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 09889322 d:ShareCapital 2024-08-31 09889322 d:ShareCapital 2023-08-31 09889322 d:RetainedEarningsAccumulatedLosses 2024-08-31 09889322 d:RetainedEarningsAccumulatedLosses 2023-08-31 09889322 c:FRS102 2023-09-01 2024-08-31 09889322 c:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 09889322 c:FullAccounts 2023-09-01 2024-08-31 09889322 c:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 09889322 e:PoundSterling 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure

Registered number: 09889322










ECO-BIOSCIENCE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2024

 
ECO-BIOSCIENCE LIMITED
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ECO-BIOSCIENCE LIMITED
FOR THE YEAR ENDED 31 AUGUST 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Eco-Bioscience Limited for the year ended 31 August 2024 which comprise  the Balance Sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the Board of Directors of Eco-Bioscience Limited, as a body, in accordance with the terms of our engagement letter dated 17 October 2022Our work has been undertaken solely to prepare for your approval the financial statements of Eco-Bioscience Limited and state those matters that we have agreed to state to the Board of Directors of Eco-Bioscience Limited, as a body, in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Eco-Bioscience Limited and its Board of Directors, as a body, for our work or for this report. 

It is your duty to ensure that Eco-Bioscience Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Eco-Bioscience Limited. You consider that Eco-Bioscience Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Eco-Bioscience Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



MA Partners LLP
 
Chartered Accountants
  
7 The Close
Norwich
Norfolk
NR1 4DJ
7 March 2025
Page 1

 
ECO-BIOSCIENCE LIMITED
REGISTERED NUMBER: 09889322

BALANCE SHEET
AS AT 31 AUGUST 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
7,562
3,376

  
7,562
3,376

Current assets
  

Stocks
  
109,727
73,580

Debtors: amounts falling due within one year
 5 
20,620
87,953

Cash at bank and in hand
  
42,492
49,041

  
172,839
210,574

Creditors: amounts falling due within one year
 6 
(43,138)
(86,319)

Net current assets
  
 
 
129,701
 
 
124,255

Total assets less current liabilities
  
137,263
127,631

  

Net assets
  
137,263
127,631


Capital and reserves
  

Called up share capital 
  
170
170

Profit and loss account
  
137,093
127,461

  
137,263
127,631


Page 2

 
ECO-BIOSCIENCE LIMITED
REGISTERED NUMBER: 09889322
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 7 March 2025.




M C Harvey
J M Pichler
Director
Director

The notes on pages 4 to 8 form part of these financial statements.

Page 3

 
ECO-BIOSCIENCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1.


General information

Eco-Bioscience Limited is a private company, limited by shares, incorporated and domiciled in England and Wales. The registered office is Glebe Barn, Ringstead, Hunstanton, PE36 5JZ.
The Company's principal activity is the production and distribution of environment friendly biological solutions.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Page 4

 
ECO-BIOSCIENCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line and reducing balance method.

Depreciation is provided on the following basis:

Plant and machinery
-
25% reducing balance
Office equipment
-
3 years straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 5

 
ECO-BIOSCIENCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).

Page 6

 
ECO-BIOSCIENCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

4.


Tangible fixed assets





Plant and machinery
Office equipment
Total

£
£
£



Cost or valuation


At 1 September 2023
3,209
3,956
7,165


Additions
-
6,943
6,943



At 31 August 2024

3,209
10,899
14,108



Depreciation


At 1 September 2023
1,817
1,972
3,789


Charge for the year on owned assets
348
2,409
2,757



At 31 August 2024

2,165
4,381
6,546



Net book value



At 31 August 2024
1,044
6,518
7,562



At 31 August 2023
1,392
1,984
3,376


5.


Debtors

2024
2023
£
£


Trade debtors
19,967
87,953

Other debtors
653
-

20,620
87,953


Page 7

 
ECO-BIOSCIENCE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
3,703
60,800

Corporation tax
25,335
14,059

Other taxation and social security
8,115
8,921

Other creditors
3,730
334

Accruals and deferred income
2,255
2,205

43,138
86,319


 
Page 8